Ausgabe 3/2022
Inhalt (21 Artikel)
Genomic landscape of colorectal carcinogenesis
Jin Cheon Kim, Walter F. Bodmer
Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment
Lihui Si, Zecheng Yang, Lu Ding, Duoduo Zhang
NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma
Yueren Yan, Zhendong Gao, Han Han, Yue Zhao, Yang Zhang, Xiangyi Ma, Haiquan Chen
Horizontal tumor extent (HZTE) has limited prognostic significance in 2018 FIGO stage I endocervical adenocarcinoma (ECA): a retrospective study of 416 cases
Simona Stolnicu, Lien Hoang, Noorah Almadani, Louise De Brot, Graziele Bovolim, Glauco Baiocchi, Maria Jose Brito, Georgia Karpathiou, Antonio Ieni, Esther Guerra Fernandez, Takako Kyiokawa, Pavel Dundr, Carlos Parra-Herran, Sofia Lérias, Ana Felix, Andres Roma, Anna Pesci, Esther Oliva, Robert A. Soslow, Nadeem R. Abu-Rustum, Kay J. Park
Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma
Shiva Sabazade, Viktor Gill, Christina Herrspiegel, Gustav Stålhammar
Expressions and significances of CTSL, the target of COVID‐19 on GBM
Qiang Dong, Qiao Li, Lei Duan, Hongyu Wang, Yunji Yan, Hang Yin, Liang Niu, He Zhang, Bo wang, Guoqiang Yuan, Yawen Pan
Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression
Leili Saeednejad Zanjani, Mahdieh Razmi, Fahimeh Fattahi, Elham Kalantari, Maryam Abolhasani, Sima Saki, Zahra Madjd, Monireh Mohsenzadegan
Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment
Christian Vay, Philipp M. Schlünder, Levent Dizdar, Irene Esposito, Markus P. H. Ghadimi, Wolfram T. Knoefel, Andreas Krieg
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients
Mette-Triin Purde, Rebekka Niederer, Nikolaus B. Wagner, Stefan Diem, Fiamma Berner, Omar Hasan Ali, Dorothea Hillmann, Irina Bergamin, Markus Joerger, Martin Risch, Christoph Niederhauser, Tobias L. Lenz, Martin Früh, Lorenz Risch, David Semela, Lukas Flatz
Solitary colorectal liver metastasis: overview of treatment strategies and role of prognostic factors
S. Acciuffi, F. Meyer, A. Bauschke, R. Croner, U. Settmacher, A. Altendorf-Hofmann
Treatment and follow-up of rare testis tumours
Christian Daniel Fankhauser, Josias Bastian Grogg, Christian Rothermundt, Noel William Clarke
A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX)
Yuan Cheng, Shu-kui Qin, Jin Li, Guang-hai Dai, Bai-yong Shen, Jie-er Ying, Yi Ba, Han Liang, Xin-bo Wang, Ye Xu, Lin Zhou, Ke-feng Ding, Yan-ru Qin, Shu-jun Yang, Wen-xian Guan, Hui Zheng, Qian Wang, Hang Song, Yan-ping Zhu
Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer
Xiaochang Qiu, Haoran Zhang, Yongheng Zhao, Jing Zhao, Yunyan Wan, Dezhi Li, Zhouhong Yao, Dianjie Lin
Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy
Aya Maekawa, Atsushi Kudo, Mitsuhiro Kishino, Yoshiki Murase, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Shinji Tanaka, Yuko Kinowaki, Minoru Tanabe
Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases
H. Prely, C. Herledan, A. G. Caffin, A. Baudouin, V. Larbre, M. Maire, V. Schwiertz, N. Vantard, F. Ranchon, C. Rioufol
Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers
Nora Tabea Sibert, Simone Wesselmann, Clara Breidenbach, Jens Blohmer, Barbara Brückner, Gerhard Gebauer, Marina dos Santos Guilherme, Andreas Hartkopf, Christoph Lindner, Susanne Peschel, Lorenz Rieger, Friedemann Schad, Paul Strecker, Julia Ferencz, Sebastian Dieng, Elisabeth C. Inwald, Christoph Kowalski, Olaf Ortmann
Biopsy-detected Gleason grade 5 tumor is an additional prognostic factor in metastatic hormone-sensitive prostate cancer
Bumjin Lim, Wonchul Lee, Yoon Soo Kyung, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim
Analysis of end-of-life treatment and physician perceptions at a university hospital in Germany
Nicole Heerde, Wolf-Karsten Hofmann, Ralf-Dieter Hofheinz, Sylvia Büttner, Deniz Gencer
Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report
Ruth-Miriam Koerber, Stefanie A. E. Held, Maria Vonnahme, Georg Feldmann, Joerg Wenzel, Ines Gütgemann, Peter Brossart, Annkristin Heine
Correction to: MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1
Xin-Long Ma, Feng Shang, Wei Ni, Jin Zhu, Bin Luo, Yu-Qi Zhang
Correction to: Inactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing’s sarcoma
Bin Pan, Xiangbo Bu, Menghan Cao, Xin Zhang, Tianqun Huo, Ziang Li, Xiao Gao, Li Jing, Xuanxiang Luo, Hu Feng, Feng Yuan, Kaijin Guo